在沙特阿拉伯的癌症患者中,临床试验意识,感知和参与
Maryam Alotaibi1, Laila Alsolami1, Sarah AlHarbi1
1Pharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia.
Healthcare (Basel, Switzerland)
|May 14, 2025
概括
沙特癌症患者对临床试验的认识适度,但面临诸如害怕副作用和缺乏信息等障碍. 加强信任和教育对于增加参与癌症临床试验至关重要.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 公共卫生 公共卫生
背景情况:
- 临床试验对于推进癌症治疗和疗法至关重要.
- 在沙特阿拉伯和中东地区,患者参与临床试验的比例特别低.
- 了解患者的观点是提高入学率的关键.
研究的目的:
- 评估沙特癌症患者的意识,感知和加入临床试验的意愿.
- 在沙特阿拉伯确定阻碍患者参加癌症临床试验的重大障碍.
主要方法:
- 通过使用自我管理的问卷进行了横截面调查.
- 该研究包括201名沙特癌症患者 (年龄≥14岁) 通过电子邮件和社交媒体.
- 数据分析涉及SPSS和千平方测试以确定关联.
主要成果:
- 观察到对临床试验的了解程度中等 (51.2%) ,社交媒体和医疗保健提供者是主要来源.
- 害怕副作用 (82.6%) 和缺乏信息 (42.8%) 是主要的障碍.
- 虽然只有5.5%的人有先前的经验,35.3%的人愿意在医生推的情况下注册.
结论:
- 需要有针对性的教育举措,以提高沙特癌症患者对临床试验的认识和信任.
- 解决关于副作用和信息缺口的担忧可以显著改善参与.
- 加强患者招生将加速该地区的癌症研究和治疗进展.
更多相关视频
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
2.1K
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
8.2K
相关概念视频
Cancer Survival Analysis
308
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
308
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview
2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
Nursing Ethical Principles II
895
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
895
Hazard Ratio
72
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
72
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
